Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.

Read more

Granules India reports completion of FDA inspection with zero observations

Read more

Urgent reforms to ensure safe medicines: Need of the hour

Read more

India pharma and healthcare funding reaches $38.6 million in November 2025

Read more

Corona Remedies announces IPO opening on 8 December 2025

Read more

Cipla launches Ciplostem cell therapy for Knee Osteoarthritis in India

Read more

Merck announces winners of the Merck Young Scientist Award 2025

Read more

Green Pharma: How the industry can reduce its carbon footprint without compromising growth

Read more

SPARC wins U.S. court ruling on Sezaby Priority Review Voucher

Read more

Innovation made in India

Read more